At the news
? BEARISHIMPACT 6/10 8-K filed Apr 24, 2026 at 16:09 ET
Q32 Bio Inc. has filed an additional prospectus supplement to raise up to $75 million through its at-the-market (ATM) offering program with Cantor Fitzgerald, following the full utilization of a prior $14.2 million ATM offering. This new shelf capacity provides continued access to equity funding for the clinical-stage biotech.
- Q32 Bio has fully drawn down a prior $14.2 million ATM offering with Cantor Fitzgerald
- Filed a new prospectus supplement to offer up to $75 million in common stock via the same ATM program
- The offering is under a shelf registration (Form S-3) declared effective April 21, 2025
- No specific use of proceeds or pricing details disclosed in this filing
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access